At the end of October of 2017, Dr. H. Richard Alexander, esteemed surgeon specializing in peritoneal mesothelioma, will be moving from his current institution, the University of Maryland, to Rutgers University in New Jersey. His new position as Chief Surgical Officer will combine administrative as well as clinical duties. As such, Dr. Alexander will also […]
In a statement released on Sunday, Bayer announced that Anetumab ravtansine, its antibody-drug conjugate (ADC) tested in mesothelioma, has missed its primary endpoint failing to improve progression-free survival in mesothelioma patients.
“Malignant pleural mesothelioma is a very difficult-to-treat tumor, and we had hoped for a better outcome for patients,” said Robert LaCaze, Executive Vice President and […]
Mesothelioma researcher and Meso Foundation grant recipient Prasad S. Adusumilli, MD, FACS, FCCP, of the Memorial Sloan Kettering Cancer Center (MSKCC) was an author on the review article CAR T-cell therapy for lung cancer and malignant pleural mesothelioma recently published in Translational Research: The Journal of Laboratory and Clinical Medicine.
Dr. Adusumilli is a thoracic surgeon-scientist […]
Dr. Anna Nowak, medical oncologist, is this year’s recipient of the Pioneer Award for her exceptional achievements and dedication in mesothelioma research.
The Mesothelioma Applied Research Foundation presents the award annually to thought-leaders and allies who have substantially contributed to the advancement of mesothelioma research, treatment, care, support, education, and advocacy.
The award will be presented at […]
Dr. Fred Hirsch, the CEO of the International Association for the Study of Lung Cancer (IASLC) and Professor at the University of Colorado School of Medicine is this year’s recipient of the Bruce Vento Hope Builder Award, named for the late Minnesota Congressman who died from mesothelioma in 2000.
The Mesothelioma Applied Research Foundation presents the […]